CBQK:QSECommercial Bank (Q.S.C.) Analysis
Data as of 2026-06-16 - not real-time
QAR 4.27
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The Commercial Bank (P.S.Q.C.) is trading at QAR 4.27, which sits just above its 20‑day SMA (4.19) but below the 50‑day (4.28) and 200‑day (4.39) averages, indicating a short‑term price weakness within a longer‑term bearish bias. Technical momentum shows a neutral RSI of 54 and a bullish MACD histogram (+0.016) despite a bearish trend direction, while volume is trending downwards, suggesting diminishing buying pressure. On the valuation side, the stock trades at a forward PE of 6.7 versus an industry average of 16.9, and a price‑to‑book of 0.66, positioning it as undervalued relative to peers. The dividend yield of 7.0% is attractive, but the sustainability flag is raised by negative operating cash flow (‑QAR 3.36 bn) and a high payout ratio of 65%, which could strain cash generation. Financially, the bank holds QAR 14.7 bn in cash against QAR 65.1 bn of debt, and a near‑zero beta (‑0.03) signals minimal market‑wide systematic risk, though the 30‑day volatility of 19.5% points to notable price swings. Overall, the company offers a value‑oriented entry with upside potential (~15% to the median analyst target of QAR 5.08) but carries medium‑term execution risk tied to cash‑flow generation and dividend sustainability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term support at QAR 4.10
- Decreasing volume indicating waning momentum
- Neutral RSI and mixed MACD signals
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued multiples (PE ~9 vs industry ~17)
- Attractive dividend yield despite cash‑flow concerns
- Analyst price target upside of ~15%
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustainable dividend risk due to negative operating cash flow
- Low systematic beta but elevated price volatility
- Balanced exposure to Qatar and Turkey markets
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin53.32%
P/E Ratio9.3
ROE7.94%
ROA1.14%
P/B Ratio0.7
Op. Cash FlowQAR-3356748032
Industry P/E16.9
Technical Analysis
TrendBearish
RSI54.4
SupportQAR 4.10
ResistanceQAR 4.31
MA 20QAR 4.19
MA 50QAR 4.28
MA 200QAR 4.39
MACDBullish
VolumeDecreasing
Fear & Greed Index92.5
Valuation
Target PriceQAR 4.94
Upside/Downside15.73%
GradeUndervalued
TypeValue
Dividend Yield7.03%
Risk Assessment
Beta-0.03
Volatility19.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.